From Surf Wiki (app.surf) — the open knowledge base
Committee on Safety of Medicines
UK independent advisory committee
UK independent advisory committee
The Committee on Safety of Medicines (CSM) was an independent advisory committee that advised the UK Licensing Authority on the quality, efficacy, and safety of medicines.
Following the thalidomide tragedy of 1957 to 1961, in 1963 the government asked Sir Derrick Dunlop to set up a committee to investigate the control and introduction of new medicines in the United Kingdom. In June 1963 the Committee on Safety of Drugs (CSD) was established. As a result of the subsequent report to the Department of Health, which reinforced the need for specially trained doctors (clinical pharmacologists) in pharmaceutical companies and academic departments of medicine, Dunlop became the first chairman of the Committee. Under the Medicines Act 1968, the CSD was replaced in 1970 by the Medicines Commission, which established the Committee on Safety of Medicines (CSM) as a Government advisory committee under Section 4 of the Act.
It was replaced on 30 October 2005 by the Commission on Human Medicines which combines the functions of both the Committee on Safety of Medicines and the Medicines Commission.
Chairs
- The first chairman of the CSD was Sir Derek Dunlop.
- The first chairman of the CSM was Sir Eric Scowan.
- 1980–1986. Professor Sir Abraham Goldberg
- 1987–1992. Professor Sir William Asscher, previously chair of the Committee on the Review of Medicines
- 1993–1998. Professor Sir Michael Rawlins
- 1999–2005. Professor Sir Alasdair Breckenridge
For later chairs, see Commission on Human Medicines
References
References
- Tansey, E. M/Yabsley. "The Committee On The Safety Of Drugs, A Personal Account".
- Tansey, E. "'The Committee on Safety of Drugs'".
- "History and Aims of the Faculty of Pharmaceutical Medicine". Royal College of Physicians.
- (4 December 1980). "How we keep unsafe drugs off the market". New Scientist.
- {{cite Q. Q29581621
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about Committee on Safety of Medicines — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report